<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28584127</article-id>
<article-id pub-id-type="pmc">5488936</article-id>
<article-id pub-id-type="publisher-id">201701201</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1701201114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity</article-title>
<alt-title alt-title-type="short">miR-211 attenuates cholinergic-induced epilepsy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7613-3166</contrib-id>
<name>
<surname>Bekenstein</surname>
<given-names>Uriya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mishra</surname>
<given-names>Nibha</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milikovsky</surname>
<given-names>Dan Z.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanin</surname>
<given-names>Geula</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zelig</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sheintuch</surname>
<given-names>Liron</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berson</surname>
<given-names>Amit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenberg</surname>
<given-names>David S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Friedman</surname>
<given-names>Alon</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-0955-526X</contrib-id>
<name>
<surname>Soreq</surname>
<given-names>Hermona</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>The Alexander Silberman Institute of Life Sciences, <institution>The Hebrew University of Jerusalem</institution>, Jerusalem 9190401, <country>Israel</country>;</aff>
<aff id="aff2"><sup>b</sup>The Edmond and Lily Safra Center for Brain Sciences, <institution>The Hebrew University of Jerusalem</institution>, Jerusalem 9190401, <country>Israel</country>;</aff>
<aff id="aff3"><sup>c</sup>Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, <institution>Ben-Gurion University of the Negev</institution>, Beer-Sheva, 8410501 <country>Israel</country>;</aff>
<aff id="aff4"><sup>d</sup>Department of Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, <institution>Ben-Gurion University of the Negev</institution>, Beer-Sheva, 8410501 <country>Israel</country>;</aff>
<aff id="aff5"><sup>e</sup>Department of Medical Neuroscience, <institution>Dalhousie University</institution>, Halifax, NS B3H 4R2, <country>Canada</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>hermona.soreq@mail.huji.ac.il</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Arthur L. Beaudet, Baylor College of Medicine, Houston, TX, and approved April 25, 2017 (received for review January 23, 2017)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: U.B., N.M., D.Z.M., D.S.G., A.F., and H.S. designed research; U.B., N.M., D.Z.M., G.H., D.Z., L.S., and A.B. performed research; D.Z.M. contributed new reagents/analytic tools; U.B. and D.Z.M. analyzed data; and U.B. and H.S. wrote the paper.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>6</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>114</volume>
<issue>25</issue>
<fpage>E4996</fpage>
<lpage>E5005</lpage>
<permissions>
<license license-type="open-access">
<license-p>Freely available online through the PNAS open access option.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201701201.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Acute traumatic stress increases the sensitivity to develop epileptic seizures in certain people. It is therefore important to discover physiological mechanisms that avoid epilepsy. To test if rapidly inducible microRNAs (miRs) could mediate such protection, we combined mouse engineering, RNA sequencing, electric recording of brain activity, and learning tests. We discovered that miR-211, originating from an epilepsy-related genomic locus, may be involved, and therefore engineered mice produce a drug-suppressible excess of brain miR-211. In these mice, suppressing miR-211 excess to the original expression levels in normal brains led to electrically recorded epilepsy and hypersensitivity to epilepsy-inducing compounds; it also modified acetylcholine receptor composition. The functional impact of miR-211 dynamics on seizure threshold may enable future development of miR-211â€“directed therapeutics.</p>
</abstract>
<abstract>
<p>Epilepsy is a common neurological disease, manifested in unprovoked recurrent seizures. Epileptogenesis may develop due to genetic or pharmacological origins or following injury, but it remains unclear how the unaffected brain escapes this susceptibility to seizures. Here, we report that dynamic changes in forebrain microRNA (miR)-211 in the mouse brain shift the threshold for spontaneous and pharmacologically induced seizures alongside changes in the cholinergic pathway genes, implicating this miR in the avoidance of seizures. We identified miR-211 as a putative attenuator of cholinergic-mediated seizures by intersecting forebrain miR profiles that were Argonaute precipitated, synaptic vesicle target enriched, or differentially expressed under pilocarpine-induced seizures, and validated TGFBR2 and the nicotinic antiinflammatory acetylcholine receptor nAChRa7 as murine and human miR-211 targets, respectively. To explore the link between miR-211 and epilepsy, we engineered dTg-211 mice with doxycycline-suppressible forebrain overexpression of miR-211. These mice reacted to doxycycline exposure by spontaneous electrocorticography-documented nonconvulsive seizures, accompanied by forebrain accumulation of the convulsive seizures mediating miR-134. RNA sequencing demonstrated in doxycycline-treated dTg-211 cortices overrepresentation of synaptic activity, Ca<sup>2+</sup> transmembrane transport, TGFBR2 signaling, and cholinergic synapse pathways. Additionally, a cholinergic dysregulated mouse model overexpressing a miR refractory acetylcholinesterase-R splice variant showed a parallel propensity for convulsions, miR-211 decreases, and miR-134 elevation. Our findings demonstrate that in mice, dynamic miR-211 decreases induce hypersynchronization and nonconvulsive and convulsive seizures, accompanied by expression changes in cholinergic and TGFBR2 pathways as well as in miR-134. Realizing the importance of miR-211 dynamics opens new venues for translational diagnosis of and interference with epilepsy.</p>
</abstract>
<kwd-group>
<kwd>acetylcholinesterase</kwd>
<kwd>cholinergic</kwd>
<kwd>EEG</kwd>
<kwd>epilepsy</kwd>
<kwd>microRNA</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">EC | European Research Council (ERC)<named-content content-type="funder-id">501100000781</named-content></funding-source>
<award-id rid="sp1">321501</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">Seventh Framework Programme (EC Seventh Framework Programme)<named-content content-type="funder-id">501100004963</named-content></funding-source>
<award-id rid="sp2">602102</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">Ministry of Agriculture and Rural Development (Israeli Ministry of Agriculture and Rural Development)<named-content content-type="funder-id">501100004576</named-content></funding-source>
<award-id rid="sp3">53140</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">Israel Science Foundation (ISF)<named-content content-type="funder-id">501100003977</named-content></funding-source>
<award-id rid="sp4">817/13</award-id>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">Israel Science Foundation (ISF)<named-content content-type="funder-id">501100003977</named-content></funding-source>
<award-id rid="sp5">717/15</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>